DANIEL M JUNIUS Insider Trading $GLYC GLYCOMIMETICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL M JUNIUS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL M JUNIUS. DANIEL M JUNIUS is Director in IDEXX LABORATORIES INC /DE ($IDXX) and Chief Executive Officer in IMMUNOGEN INC ($IMGN) and Director in IMMUNOGEN INC ($IMGN) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and Director in GLYCOMIMETICS INC ($GLYC).
DANIEL M JUNIUS in GLYCOMIMETICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL M JUNIUS: Director
Holdings: 38,000 shares
Current Value: $237,880
Latest Transaction: May 27 2020
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL M JUNIUS in GLYCOMIMETICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GLYC, IDXX, IMGN, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2020 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 3.00 | 21,000 | 63,000 | 21,000 | |
| Mar 10 2020 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Buy | P | 3.40 | 20,000 | 68,000 | 38,000 | 18 K to 38 K (+111.11 %) |
| Aug 15 2019 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Buy | P | 3.18 | 10,000 | 31,800 | 18,000 | 8 K to 18 K (+125.00 %) |
| Aug 15 2019 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Buy | P | 3.18 | 10,000 | 31,800 | 18,000 | 8 K to 18 K (+125.00 %) |
| May 21 2019 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 12.39 | 21,000 | 260,190 | 21,000 | |
| Jun 16 2017 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Grant | A | 11.27 | 3,000 | 33,810 | 8,000 | 5 K to 8 K (+60.00 %) |
| May 30 2017 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 13.89 | 11,000 | 152,790 | 11,000 | |
| Dec 21 2016 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Buy | P | 6.01 | 5,000 | 30,050 | 5,000 | 0 to 5 K |
| May 19 2016 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 6.35 | 11,000 | 69,850 | 11,000 | |
| Mar 21 2016 | GLYC | GLYCOMIMETICS INC | JUNIUS DANIEL M | Director | Option Exercise | A | 5.99 | 22,000 | 131,780 | 22,000 |
Page: 1